IL113992A0 - Use of copolymer-1 - Google Patents
Use of copolymer-1Info
- Publication number
- IL113992A0 IL113992A0 IL11399295A IL11399295A IL113992A0 IL 113992 A0 IL113992 A0 IL 113992A0 IL 11399295 A IL11399295 A IL 11399295A IL 11399295 A IL11399295 A IL 11399295A IL 113992 A0 IL113992 A0 IL 113992A0
- Authority
- IL
- Israel
- Prior art keywords
- copolymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9411292A GB9411292D0 (en) | 1994-06-06 | 1994-06-06 | Pharmaceuticals compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
IL113992A0 true IL113992A0 (en) | 1995-10-31 |
Family
ID=10756253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11399295A IL113992A0 (en) | 1994-06-06 | 1995-06-02 | Use of copolymer-1 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0767672A1 (en) |
JP (1) | JPH10500695A (en) |
AU (1) | AU2787495A (en) |
CA (1) | CA2192218A1 (en) |
GB (1) | GB9411292D0 (en) |
IL (1) | IL113992A0 (en) |
WO (1) | WO1995033475A1 (en) |
ZA (1) | ZA954469B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214791B1 (en) | 1997-01-10 | 2001-04-10 | Yeda Research And Development Co. Ltd. | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
ES2527760T3 (en) | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Treatment of Crohn's disease with copolymer 1 and polypeptides |
EP1098902A4 (en) | 1998-07-23 | 2002-07-24 | Yeda Res & Dev | Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
US6800287B2 (en) | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
US7022663B2 (en) | 2000-02-18 | 2006-04-04 | Yeda Research And Development Co., Ltd. | Oral, nasal and pulmonary dosage formulations of copolymer 1 |
US20020077278A1 (en) | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
HUP0302333A3 (en) * | 2000-06-05 | 2005-07-28 | Teva Pharma | The use of glatiramer acetate (copolymer 1) for the preparation of pharmaceutical compositions available in the treatment of central nervous system disorders |
WO2002076503A1 (en) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Treatment of central nervous system diseases by antibodies against glatiramer acetate |
AU6887101A (en) * | 2000-06-20 | 2002-01-02 | Caprion Pharmaceuticals, Inc. | Copolymers and methods of treating prion-related diseases |
US7429374B2 (en) | 2001-12-04 | 2008-09-30 | Teva Pharmaceutical Industries, Ltd. | Process for the measurement of the potency of glatiramer acetate |
CN101044188B (en) | 2004-10-29 | 2010-08-04 | 桑多斯股份公司 | Processes for preparing glatiramer |
-
1994
- 1994-06-06 GB GB9411292A patent/GB9411292D0/en active Pending
-
1995
- 1995-05-31 ZA ZA954469A patent/ZA954469B/en unknown
- 1995-06-02 IL IL11399295A patent/IL113992A0/en unknown
- 1995-06-05 WO PCT/EP1995/002125 patent/WO1995033475A1/en not_active Application Discontinuation
- 1995-06-05 JP JP8500007A patent/JPH10500695A/en active Pending
- 1995-06-05 EP EP95923229A patent/EP0767672A1/en not_active Withdrawn
- 1995-06-05 AU AU27874/95A patent/AU2787495A/en not_active Abandoned
- 1995-06-05 CA CA002192218A patent/CA2192218A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB9411292D0 (en) | 1994-07-27 |
JPH10500695A (en) | 1998-01-20 |
CA2192218A1 (en) | 1995-12-14 |
WO1995033475A1 (en) | 1995-12-14 |
AU2787495A (en) | 1996-01-04 |
EP0767672A1 (en) | 1997-04-16 |
ZA954469B (en) | 1996-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2298422B (en) | Compounds and their use | |
GB9420657D0 (en) | Contrast agents | |
GB9526560D0 (en) | Use of 2-Amino-Heterocycles | |
EP0785806A4 (en) | Single use syringe | |
GB9500856D0 (en) | Composition and use | |
ZA951232B (en) | Contrast agents | |
ZA957113B (en) | Use of N-substituted pyhenothiazines | |
GB9418762D0 (en) | Use of substituted cyclopentane-DI-and-triones | |
IL113992A0 (en) | Use of copolymer-1 | |
ZA959517B (en) | Leutherobin and analogs thereof | |
HU9700071D0 (en) | Use of muramilpeptides | |
GB9414157D0 (en) | Medical use | |
ZA96725B (en) | Use of phenyclyclohexylcarboxamides | |
GB9411045D0 (en) | Compounds and use | |
HUP9901448A3 (en) | Novel medical use | |
GB9508637D0 (en) | New use | |
ZA9510848B (en) | Mutable composition | |
ZA963484B (en) | New use | |
GB9512703D0 (en) | Composition and use | |
IL117844A0 (en) | Use of (s)-adenosyl-l-methionine | |
GB9516136D0 (en) | New Use | |
GB9520119D0 (en) | Use | |
GB9519905D0 (en) | Use | |
GB9505071D0 (en) | Use | |
GB9519915D0 (en) | Use |